Skip to content
UK company record
Grey Wolf Therapeutics
Immuno-oncology
CandidateCore UK
Snapshot
- UK location
- Oxford · South East
- Sector
- Biotech & techbio
- Latest recorded round
- Series B
- Latest recorded amount
- £39.5M
- Date
- 2023-01-01
Legal-identity layer
Candidate identity.
- Selected legal name
- GREY WOLF THERAPEUTICS LIMITED
- Company number
- 10989365
- Companies House status
- active
- Incorporated
- 2017-09-29
Current directors and active controllers
- AHRENS, Brenton KarlCurrent director
- HERCEND, Thierry, DrCurrent director
- JOYCE, PeterCurrent director
- MARCHINGTON, Allan Patrick, DrCurrent director
- MCCARTHY, Thomas DavidCurrent director
- MOSES, EdwinCurrent director
- NASRALLAH, RababCurrent director
- PEAKMAN, Marie-Claire, DrCurrent director
- SMIRNYAGINA, Ekaterina, DrCurrent director
- STAINER, Paul John GrattanCurrent director
- WISNIEWSKI, RaphaelCurrent director
- Biodiscovery 5 FpciFormer controller
- Canaan Xi L.P.Former controller
- DEWHURST, Sally Marianne, Dr.director
- HARRIS, Samantha Annsecretary
- JOHNSON, Emmadirector
- Mr Peter JoyceFormer controller
- ONIONS, Stuart Thomasdirector
- Thomas David MccarthyFormer controller
- WEIGHTMAN, Tracydirector
Funding rows
- Series B£39.5M · 2023-01-01